Callidus Software has signed a leading pharmaceutical company as a new customer for its on-demand Monaco suite. Under the agreement, signed in the fourth quarter of 2009, the new customer will deploy the Callidus Monaco Suite for its direct sales force in the US.
The Callidus on-demand Monaco Suite provides an end-to-end performance management platform. It enables businesses to optimise the entire sales lifecycle from sales on-boarding, to quota and plan deployment and payment. The company’s solutions give actionable insight into sales execution and channel operations and provide the tools to fine-tune sales performance.
Jeff Saling, senior vice president of global sales at Callidus Software, said: This is yet another new pharmaceutical customer that we have signed this year and we are very pleased with our ongoing momentum in the pharmaceutical industry.
“Callidus Monaco leads the SPM market with its unbeatable combination of ease of use and deep functionality, delivered by our SAS-70 compliant on-demand offering. SaaS for SPM is great for SMBs, but it is also expanding into the enterprise market, as demonstrated by our agreements with some of the leading pharmaceutical companies. These customers have selected us to replace their existing and frequently inflexible legacy solutions with SaaS from the SPM market-leader. Callidus Software now provides its solutions to three of the top five US-pharmaceutical companies.
Content from our partners
